Sequence46, LLC

LOS ANGELES, CA · Founded 2017 · CIK 0001804148 · Biotech · Private

Preimplantation genetic testing (PGT) for IVF embryo screening

sequence46.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$48K
1 Form D · Feb 2020
79 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$48,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2673Advanced Gene Transfer Company, Inc.——
2674ITERION THERAPEUTICS INC. ——
2675Qu Biologics Inc.—$49K
2676Sequence46, LLC—$48K
2677Forkhead Biotherapeutics, Inc.——
2678Arcus, Inc.—$35K
2679Extended Longevity, Inc.—$10K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Susan ChristoffersonExecutive Officer
  • Kyle FrancisExecutive Officer
  • Gary NakhudaExecutive Officer
  • Sophia TormasiPromoter
  • Catherine WelchDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.